Long Covid

#Long Covid #Oncology #Pancreatic cancer

DDW Highlights: 7 October 2025

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry news. This week’s news is led by the agreement by Genmab to acquire Merus, an announcement… Read More

#Podcasts

#Cancer research #Gene therapy #Long Covid

This week in Drug Discovery (29 September – 3 October)

News round-up for 29 September – 3 October by Bruno Quinney, Content Team at DDW.  This week’s news is led by the agreement by Genmab to acquire Merus in a deal worth approximately $8 billion, an announcement which could have important ramifications in cancer research. Scientists have… Read More

#News

Long Covid concept
#Covid-19 #Genetics / genomics #Long Covid #Oncology #Spatial biology

Enhancing cancer and long Covid research

Genomic and spatial technologies are helping to bring greater insights into cancer and diseases such as long Covid, writes Jack DiGiovanna, Chief Science Officer at Velsera. Emerging genomic and spatial technologies are transforming research on complex diseases like cancer and long Covid. These advancements offer unprecedented precision in diagnostics and… Read More

#Cancer Research #Exclusive Content

#Astex Pharmaceuticals #Bioorthogonal chemistry #Click chemistry #Cognitive impairment #Covid-19 #Drug discovery #Life sciences #Long Covid #Molecular Biology #Neuroscience #Public health

Podcast: Innovative approaches to improving drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Innovative approaches to improving drug discovery”, which covers three articles written for DDW Volume 24 – Issue 2, Spring 2023 of DDW. They are called: Post-Covid cognitive impairment: a new target for drug development?, Sitting Down… Read More

#News

T cell attacking Covid-19
#Anti-virals #Covid-19 #Hyundai Bioscience #Long Covid #University of California San Diego

Hyundai Bioscience investigates antiviral for long Covid in US trial

Hyundai Bioscience USA and the University of California San Diego (UCSD) have agreed to conduct a clinical trial to evaluate the efficacy of Xafty, a niclosamide-based antiviral, in treating long Covid. “This is an outstanding opportunity for UCSD  and Hyundai Bioscience to partner together to tackle… Read More

#News

#Chronic Fatigue Syndrome #Long Covid #Metrodora Institute #Partnership #PrecisionLife

Partners to advance personalised treatments for long Covid

PrecisionLife and the Metrodora Institute have agreed a partnership to jumpstart the diagnosis and treatment options for a range of complex, chronic diseases. The diseases include long Covid, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), amyotrophic lateral sclerosis (ALS), Sjögren’s syndrome, and many more. The partners… Read More

#News

Patient receiving a vaccine
#Covid-19 #Covid-19 vaccine #Immunology / Virology & Vaccines #Long Covid

Covid-19 vaccines found to protect against long Covid

A study has revealed that Covid-19 vaccines are effective in preventing long Covid, but the BioNTech/Pfizer vaccine provided better protection than ChAdOx1, developed by Oxford University/AstraZeneca. A research team at NDORMS (Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences), University of Oxford has found that vaccination… Read More

#News #Trending News

Hospital patient on ventilator
#Biomarkers #Collaboration #Covid-19 #GeNeuro #Long Covid #Personalised medicine #Verily

Partners take a personalised approach to long Covid

GeNeuro and Verily will work together to investigate biomarkers related to activation of the proinflammatory HERV-W envelope protein (W-ENV) in SARS-CoV-2 infection. Through this collaboration, the companies will build on results published earlier this year, which evidenced the in vitro activation of HERV-W by SARS-CoV-2 in… Read More

#Editor's Choice #News

Long Covid
#Antivirals #Burton NHS Foundation Trust #Covid-19 #Gilead Sciences #Long Covid #University Hospitals of Derby #University of Exeter

Could a common antiviral treat long Covid?

A UK-based study will investigate whether a common anti-viral medication could double up as a treatment for long Covid. The project involves teams from the University Hospitals of Derby and Burton NHS Foundation Trust and the University of Exeter, in collaboration with Gilead Sciences. Read More

#News #Trending News

#Autoimmune disease #Axcella Therapeutics #Chronic Fatigue Syndrome #Covid-19 #Long Covid

Long Covid: A call to action for drug developers

According to the National Institutes for Health, some form of long Covid affects around 10% of people infected with Covid-19, with fatigue being the most common symptom. Despite the size of the market and the global impact, there are currently no effective treatments. Diana Spencer caught up with Bill Hinshaw,… Read More

#Exclusive Content

Long Covid
#Covid-19 #Immunology #Long Covid #Psychiatry #SARS-CoV-2

New post-Covid study links infection and retrovirus 

A Translational Psychiatry publication indicates that SARS-CoV-2 infection, even when unnoticed or asymptomatic, can have an influence on the activation of the Human Endogenous Retrovirus W (W-ENV) protein in psychotic patients, in a context of innate immune inflammation.   GeNeuro, a biopharmaceutical company developing treatments… Read More

#Covid-19 #News

#Artificial intelligence (AI) #Breast cancer #Head and neck cancer #Immunotherapy #Long Covid #Monoclonal antibodies #Oncology #Parkinson's #Stem cells

New DDW Highlights podcast out now

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  This week’s headline news features a stem-cell derived Parkinson’s therapy, a monoclonal antibody for… Read More

#News

#Artificial intelligence (AI) #Breast cancer #Head and neck cancer #Immunotherapy #Long Covid #Monoclonal antibodies #Oncology #Parkinson's #Stem cells

This week in drug discovery (28 August – 1 September)  

News round-up for 28 August – 1 September by DDW Digital Content Editor Diana Spencer. This week’s headline news features a stem-cell derived Parkinson’s therapy, a monoclonal antibody for head and neck cancer, an estrogen receptor degrader for breast cancer, a mitochondrial activator for long Covid,… Read More

#News

Long Covid
#Axcella Therapeutics #Covid-19 #Long Covid #US patent

Axcella granted US patent for long Covid fatigue treatment

The US Patent and Trademark Office (USPTO) has granted a patent for Axcella Therapeutics’ long Covid treatment candidate AXA1125. AXA1125 is a novel composition of endogenous metabolic modulators (EMMs) designed to simultaneously support metabolic, inflammatory and fibrotic pathways associated with fatigue. In April, The… Read More

#News

#Biomedical research #Clinical trials #Laboratory data #Long Covid #Neuroscience #Oncology #Trial data

New DDW Highlights episode now available

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The most impactful drug discovery news this week is all linked with scientific research… Read More

#News